Published on: Signal Transduction and Targeted Therapy (Nature) A new study demonstrates how engineered immune cells can be programmed to...

Published on: LinkedIn (Spencer Knight) The U.S. FDA has approved DAWNZERA (donidalorsen) from Ionis Pharmaceuticals, the first...

Published on: Penn Medicine Researchers at the University of Pennsylvania have identified a muscle-derived stem cell, Prg4+, that can...

Published on: LinkedIn (Spencer Knight) In just five days, two breakthrough approvals have reshaped treatment for metabolic...

Published on: LinkedIn (Spencer Knight) The CGT field saw a breakthrough weekend with multiple milestones. Precigen secured FDA approval...

Published on: Autolus Therapeutics The European Commission has granted marketing authorization for AUCATZYL (obecabtagene autoleucel) to...

Published on: Precigen Investors The U.S. FDA has granted full approval to PAPZIMEOS (zopapogene imadenovec-drba), the first therapy for...

Published on: Alliance for Regenerative Medicine The Alliance for Regenerative Medicine’s Q2 2025 Sector Snapshot showcases pivotal...

Published on: Cytotherapy CAR T-cell therapy has transformed outcomes for aggressive B-cell Non-Hodgkin lymphoma, yet many eligible...

Published on: Forbes A clinical trial by Vertex Pharmaceuticals has shown that lab-grown stem cell–derived islet cells can restore...

Published on: Multiple Sclerosis News Today A U.S. trial has treated the first multiple sclerosis (MS) patient with azercabtagene...

Published on: LinkedIn (Spencer Knight) A groundbreaking case in glioblastoma treatment has emerged from a U.S. clinical trial. Pamela...

Published in ACS Applied Materials & Interfaces Researchers report Gas6-engineered neural stem cell membrane–coated nanoparticles...

Published by Harvard Medical School This HMS explainer walks through modern immunotherapy, from checkpoint inhibitors that release immune...

Published on Cytotherapy via LinkedIn Cytotherapy’s new podcast features CAR-T pioneer Bruce Levine in conversation with Patrick Hanley....

Published on LinkedIn via Spencer Knight The FDA has given accelerated approval to Jazz Pharmaceuticals’ Modeyso (dordaviprone) for...

Published by UMC Utrecht In the PASSIoN safety study at UMC Utrecht, ten newborns with perinatal stroke received a single dose of...

Published in The Japan Times Sumitomo Pharma has applied for regulatory approval in Japan to market a cell therapy that transplants...

Published on ISCT Telegraft Blog by Francheska Juliano At the ISCT 2024 Annual Meeting in Vancouver, global experts discussed how access...

Published in Regenerative Therapy (Vol. 30, Dec 2025) A study in Regenerative Therapy shows that adipose-derived stem cells (ADSCs)...